AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sorrento Therapeutics, Inc.

$0 -$0.00 (-87.30%)
OTC · 15 Sep 2026 15:43 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0.05
Market Cap
220.51K
AVG Volume
263.11K
Trailing/Forward PE
-0/0
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
Other OTCUS
Revenue (USD)
050M100M150M200M2013201420152016201720182019202020212022
SRNE Revenue (USD) by year
PeriodRevenue (USD)
202262.84M
202152.9M
202039.99M
201931.43M
201821.19M
2017151.86M
20168.15M
20154.59M
20143.83M
2013460.15K
Net Income (USD)
-600M-400M-200M0200M2013201420152016201720182019202020212022
SRNE Net Income (USD) by year
PeriodNet Income (USD)
2022-574.74M
2021-428.32M
2020-298.46M
2019-292.07M
2018-203.54M
20179.13M
2016-60.92M
2015-45.81M
2014-34.66M
2013-21.91M
Operating Income (USD)
-600M-400M-200M0200M2013201420152016201720182019202020212022
SRNE Operating Income (USD) by year
PeriodOperating Income (USD)
2022-478.53M
2021-380.53M
2020-244.52M
2019-259.39M
2018-150.42M
201725.34M
2016-96.78M
2015-74M
2014-34.74M
2013-21.67M
EBITDA (USD)
-600M-400M-200M0200M2013201420152016201720182019202020212022
SRNE EBITDA (USD) by year
PeriodEBITDA (USD)
2022-536.93M
2021-436.77M
2020-283.77M
2019-312.47M
2018-147.09M
201726.14M
2016-66.85M
2015-9.74M
2014-31.55M
2013-20.37M
Cash Flows (USD)
-400M-300M-200M-100M02013201420152016201720182019202020212022
SRNE Cash Flows (USD) by year
PeriodCash Flows (USD)
2022-307.51M
2021-290.69M
2020-197.12M
2019-184.44M
2018-122.96M
2017-110.15M
2016-77.75M
2015-45.78M
2014-29.36M
2013-17.42M
EPS (USD)
-3-2-102013201420152016201720182019202020212022
SRNE EPS (USD) by year
PeriodEPS (USD)
2022-1.38
2021-1.43
2020-1.33
2019-2.11
2018-1.92
2017-0.06
2016-1.46
2015-1.24
2014-1.27
2013-1.28
Expenses (USD)
0200M400M600MR&DSG&ACapex2013201420152016201720182019202020212022
SRNE Expenses (USD) by year
PeriodExpenses (USD)
2022417.22M
2021410.59M
2020265.1M
2019221.88M
2018151.8M
2017104.83M
201673.25M
201555.18M
201434.56M
201316.38M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt2013201420152016201720182019202020212022
SRNE Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202249.98M
2021126.88M
202056.46M
201922.52M
2018159.03M
201720.87M
201683.5M
2015136.4M
201471.9M
201331.67M
Debt ratios
-101220152016201720182019202020212022
SRNE Debt ratios by year
PeriodDebt ratios
2022-0.05
2021-0.09
2020-0.16
2019-0.54
2018-0.38
20170.19
20160.28
20151.92
Margins
0%25%50%75%100%2013201420152016201720182019202020212022
SRNE Margins by year
PeriodMargins
202246.77%
202167.64%
202075.14%
201961.07%
201866.69%
201797.4%
201673.7%
201557.52%
201446.59%
201399.04%
Return on Capital
-1000%0%1000%2000%3000%2013201420152016201720182019202020212022
SRNE Return on Capital by year
PeriodReturn on Capital
20222652.37%
2021-548.23%
2020-212.08%
2019-891.65%
2018-98.09%
20174.58%
2016-70.43%
2015-32.5%
2014-31.88%
2013-32.8%
Shares Outstanding
0200M400M600M2013201420152016201720182019202020212022
SRNE Shares Outstanding by year
PeriodShares Outstanding
2022435.47M
2021308.85M
2020251.21M
2019182.61M
2018122.28M
201784.94M
201650.89M
201537.97M
201436.21M
201323.05M
Book Value Per Share (USD)
-1012342013201420152016201720182019202020212022
SRNE Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2022-0.05
20210.25
20200.56
20190.18
20181.7
20172.35
20161.7
20153.71
20143
20132.9
Total Assets (USD)
0200M400M600M800M2013201420152016201720182019202020212022
SRNE Total Assets (USD) by year
PeriodTotal Assets (USD)
2022472.84M
2021694.82M
2020535.82M
2019557.63M
2018624.09M
2017431.61M
2016401.59M
2015343.52M
2014141.54M
201392.58M
Employee Count
02505007501K2013201420152016201720182019202020212022
SRNE Employee Count by year
PeriodEmployee Count
2022949
2021799
2020502
2019310
2018382
2017162
2016154
201597
201466
201350
PE Ratio
0.580.590.590.6Apr 18May 18
SRNE PE Ratio by year
PeriodPE Ratio
May 180.6
Apr 180.59
Free Cash Flow Yield
-150000%-100000%-50000%0%med -30462.16%Jan 25May 25Sep 25Jan 26May 26Sep 26
SRNE Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-110294.02%
Sep 26-110294.02%
Sep 26-73529.35%
Aug 26-88235.22%
Aug 26-55147.01%
Aug 26-63025.16%
Aug 26-88235.22%
Jul 26-88235.22%
Jul 26-110294.02%
Jul 26-44117.61%
Jul 26-63025.16%
Jul 26-80213.84%
Jun 26-44117.61%
Jun 26-40106.92%
Jun 26-49019.57%
Jun 26-88235.22%
May 26-88235.22%
May 26-88235.22%
May 26-73529.35%
May 26-49019.57%
May 26-88235.22%
Apr 26-49019.57%
Apr 26-55147.01%
Apr 26-19181.57%
Apr 26-13786.75%
Mar 26-18382.34%
Mar 26-14231.49%
Mar 26-11609.9%
Mar 26-9191.17%
Feb 26-27573.51%
Feb 26-11609.9%
Feb 26-17647.04%
Feb 26-17647.04%
Jan 26-17647.04%
Jan 26-12605.03%
Jan 26-12605.03%
Jan 26-14231.49%
Jan 26-14005.59%
Dec 25-13786.75%
Dec 25-24509.78%
Dec 25-11312.21%
Dec 25-11923.68%
Nov 25-5584.51%
Nov 25-6787.32%
Nov 25-4901.96%
Nov 25-4901.96%
Oct 25-5656.1%
Oct 25-7352.93%
Oct 25-6302.52%
Oct 25-7352.93%
Oct 25-12605.03%
Sep 25-12605.03%
Sep 25-8823.52%
Sep 25-12605.03%
Sep 25-11923.68%
Aug 25-7352.93%
Aug 25-10259.91%
Aug 25-21008.39%
Aug 25-29411.74%
Aug 25-29411.74%
Jul 25-31512.58%
Jul 25-31512.58%
Jul 25-18382.34%
Jul 25-33936.62%
Jun 25-20053.46%
Jun 25-20053.46%
Jun 25-21008.39%
Jun 25-21008.39%
May 25-33936.62%
May 25-33936.62%
May 25-40106.92%
May 25-21008.39%
May 25-49019.57%
Apr 25-44117.61%
Apr 25-49019.57%
Apr 25-44117.61%
Apr 25-44117.61%
Mar 25-63025.16%
Mar 25-63025.16%
Mar 25-63025.16%
Mar 25-63025.16%
Feb 25-88235.22%
Feb 25-73529.35%
Feb 25-73529.35%
Feb 25-88235.22%
Jan 25-110294.02%
Jan 25-88235.22%
Jan 25-88235.22%
Jan 25-73529.35%
Jan 25-73529.35%
Dec 24-63025.16%
Dec 24-55147.01%
Dec 24-29411.74%
Dec 24-36764.67%
Nov 24-29411.74%
Nov 24-17647.04%
Nov 24-12605.03%
Nov 24-4411.76%
Nov 24-16339.86%
Oct 24-12254.89%
Price to Sales
00.030.050.080.1med 0.01Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SRNE Price to Sales by year
PeriodPrice to Sales
Sep 260
Sep 260
Sep 260.01
Aug 260
Aug 260.01
Aug 260.01
Aug 260
Jul 260
Jul 260
Jul 260.01
Jul 260.01
Jul 260
Jun 260.01
Jun 260.01
Jun 260.01
Jun 260
May 260
May 260
May 260.01
May 260.01
May 260
Apr 260.01
Apr 260.01
Apr 260.02
Apr 260.03
Mar 260.02
Mar 260.03
Mar 260.03
Mar 260.04
Feb 260.01
Feb 260.03
Feb 260.02
Feb 260.02
Jan 260.02
Jan 260.03
Jan 260.03
Jan 260.03
Jan 260.03
Dec 250.03
Dec 250.02
Dec 250.03
Dec 250.03
Nov 250.07
Nov 250.06
Nov 250.08
Nov 250.08
Oct 250.07
Oct 250.05
Oct 250.06
Oct 250.05
Oct 250.03
Sep 250.03
Sep 250.04
Sep 250.03
Sep 250.03
Aug 250.05
Aug 250.04
Aug 250.02
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.02
Jul 250.01
Jun 250.02
Jun 250.02
Jun 250.02
Jun 250.02
May 250.01
May 250.01
May 250.01
May 250.02
May 250.01
Apr 250.01
Apr 250.01
Apr 250.01
Apr 250.01
Mar 250.01
Mar 250.01
Mar 250.01
Mar 250.01
Feb 250
Feb 250.01
Feb 250.01
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250.01
Jan 250.01
Dec 240.01
Dec 240.01
Dec 240.01
Dec 240.01
Nov 240.01
Nov 240.02
Nov 240.03
Nov 240.09
Nov 240.02
Oct 240.03
EV/EBITDA
-20-15-10-50med -0.65Jan 16Nov 17Jan 18Apr 18Jun 18Aug 18Nov 18
SRNE EV/EBITDA by year
PeriodEV/EBITDA
Nov 18-7.2
Oct 18-7.35
Oct 18-7.29
Oct 18-7.23
Oct 18-7.12
Sep 18-7
Sep 18-7.03
Sep 18-7.02
Sep 18-6.84
Aug 18-6.68
Aug 18-6.66
Aug 18-6.73
Aug 18-6.72
Aug 18-0.74
Jul 18-0.73
Jul 18-0.69
Jul 18-0.64
Jul 18-0.65
Jun 18-0.64
Jun 18-0.67
Jun 18-0.63
Jun 18-0.62
Jun 18-0.61
May 18-0.61
May 18-0.64
May 18-0.62
May 18-0.39
Apr 18-0.39
Apr 18-0.14
Apr 18-0.15
Apr 18-0.15
Mar 18-0.16
Mar 18-0.13
Mar 18-0.12
Mar 18-0.12
Mar 18-0.13
Feb 18-0.1
Feb 18-0.1
Feb 18-0.13
Feb 18-0.12
Jan 18-0.12
Jan 18-0.14
Jan 18-0.16
Jan 18-0.16
Dec 17-0.18
Dec 17-0.18
Dec 17-0.19
Dec 17-0.2
Dec 17-0.2
Nov 17-0.2
Nov 17-0.2
Nov 17-0.19
Mar 16-19.01
Mar 16-18.99
Feb 16-18.98
Feb 16-19
Feb 16-19.03
Feb 16-19.06
Jan 16-19.05
Jan 16-18.99
Jan 16-19
Jan 16-18.93
Dec 15-18.83
Dec 15-18.78
Dec 15-18.88
Dec 15-18.9
Dec 15-18.88
Nov 15-18.85
Nov 15-18.89
Price to Book
00.050.10.150.2med 0.07Jun 21Sep 21Dec 21Apr 22Jul 22Nov 22Feb 23
SRNE Price to Book by year
PeriodPrice to Book
Feb 230.01
Feb 230.01
Feb 230.03
Feb 230.04
Jan 230.04
Jan 230.04
Jan 230.04
Jan 230.04
Dec 220.03
Dec 220.03
Dec 220.04
Dec 220.04
Dec 220.04
Nov 220.05
Nov 220.05
Nov 220.06
Nov 220.04
Oct 220.05
Oct 220.05
Oct 220.04
Oct 220.04
Sep 220.05
Sep 220.05
Sep 220.06
Sep 220.07
Sep 220.06
Aug 220.06
Aug 220.06
Aug 220.04
Aug 220.04
Jul 220.04
Jul 220.04
Jul 220.04
Jul 220.04
Jul 220.03
Jun 220.03
Jun 220.03
Jun 220.02
Jun 220.03
May 220.02
May 220.02
May 220.02
May 220.02
Apr 220.06
Apr 220.07
Apr 220.07
Apr 220.08
Apr 220.09
Mar 220.1
Mar 220.1
Mar 220.09
Mar 220.05
Feb 220.06
Feb 220.06
Feb 220.07
Feb 220.07
Jan 220.07
Jan 220.09
Jan 220.1
Jan 220.1
Dec 210.11
Dec 210.13
Dec 210.14
Dec 210.14
Dec 210.11
Nov 210.14
Nov 210.14
Nov 210.15
Nov 210.15
Oct 210.11
Oct 210.1
Oct 210.11
Oct 210.1
Oct 210.11
Sep 210.12
Sep 210.13
Sep 210.12
Sep 210.14
Aug 210.14
Aug 210.13
Aug 210.14
Aug 210.13
Jul 210.1
Jul 210.1
Jul 210.1
Jul 210.11
Jul 210.12
Jun 210.12
Jun 210.1
Jun 210.11
Jun 210.1
May 210.09
May 210.09
May 210.08
May 210.09
Apr 210.15
Apr 210.14
Apr 210.13
Apr 210.13
Apr 210.14
Sorrento Therapeutics, Inc.
SRNE
Stockpicker

Video analysis: SRNE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.